- Report
- August 2025
- 200 Pages
United States
From €2199EUR$2,490USD£1,923GBP
- Report
- August 2025
- 200 Pages
United States
From €2199EUR$2,490USD£1,923GBP
- Report
- July 2025
- 200 Pages
Europe
From €2199EUR$2,490USD£1,923GBP
- Report
- August 2025
- 200 Pages
United States
From €2199EUR$2,490USD£1,923GBP
- Report
- August 2025
- 200 Pages
United States
From €2199EUR$2,490USD£1,923GBP
- Report
- February 2025
- 100 Pages
Europe
From €2870EUR$3,250USD£2,510GBP
- Report
- July 2025
- 82 Pages
United States
From €3091EUR$3,500USD£2,704GBP
- Report
- May 2025
- 85 Pages
United States
From €3091EUR$3,500USD£2,704GBP
- Report
- April 2025
- 133 Pages
Europe
From €3532EUR$4,000USD£3,090GBP
- Report
- July 2025
- 350 Pages
North America
From €3417EUR$3,869USD£2,989GBP
- Report
- June 2025
- 315 Pages
Africa
From €3047EUR$3,450USD£2,665GBP
- Report
- October 2025
- 96 Pages
Middle East
From €4283EUR$4,850USD£3,746GBP
- Report
- October 2025
- 87 Pages
United States
From €4283EUR$4,850USD£3,746GBP
- Report
- October 2025
- 82 Pages
Middle East
From €4283EUR$4,850USD£3,746GBP
- Report
- October 2025
- 98 Pages
Middle East
From €4283EUR$4,850USD£3,746GBP
- Report
- October 2025
- 90 Pages
Europe
From €2440EUR$2,763USD£2,134GBP
€2870EUR$3,250USD£2,510GBP
- Report
- September 2025
- 60 Pages
United States
From €1914EUR$2,168USD£1,674GBP
€2252EUR$2,550USD£1,970GBP
- Report
- September 2025
- 90 Pages
North America
From €2440EUR$2,763USD£2,134GBP
€2870EUR$3,250USD£2,510GBP
- Report
- September 2025
- 90 Pages
North America
From €2440EUR$2,763USD£2,134GBP
€2870EUR$3,250USD£2,510GBP
- Report
- September 2025
- 373 Pages
Europe
From €5294EUR$5,995USD£4,631GBP

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more